According to Nanopharma head Liliana Berezkinová, the company participates in the research project ThymiStem. The project with a budget of GBP 5 mln (roughly CZK 165.94 mln) includes also six other research workstations including immunologists, biologists and tissue engineers. Nanopharma will contribute in the creation of a functional thymic organoid, which could significantly contribute in the improvement of the defence system of immune-compromised patients.
